GLI2 and Ewing sarcoma: Furthermore, activation of Gli1 (a Gli2 transcriptional target) seems to be a major downstream effector of the EWS-FLI1 oncoprotein which drives another SRBC tumor, Ewing Sarcoma [33], [34].